Previously, Gareus et al. demonstrated that endothelium-specific genetic depletion of IKKγ or IκBα, key signaling molecules in the NF-κB pathway, was sufficient to significantly reduce atherosclerosis in ApoE–/– mice (33). The gene discussed is NFKB1; the disease is atherosclerosis.